Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 145 - 156 of 433

EASL Studio S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition

Description

In this episode of EASL studio, learn about the clinical management and treatment of hepatitis D infection in the era of emerging treatments.

  • What does the clinical management of Hepatitis Delta infection look like in the era of emerging new treatments?
  • What is the prevalence of anti-HDV and HDV RNA positivity?
  • How do you manage HBV-HDV co-infected patients?

This project has been made possible with the provision of a financial grant from Gilead Sciences Europe Ltd. 

EASL has received no input from Gilead with regards to the content of this programme.

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Moderator

 
Magdalena Filipowicz Sinnreich PD. Dr. med. Dr. phil. Magdalena Filipowicz Sinnreich is the head of the Liver Immunology Laboratory at the Department of Biomedicine of the University Hospital in Basel, Switzerland, and the head of the liver service at the Gastroenterology Department of the Kantonsspital Baselland, a hospital affiliated with the University of Basel. She is a lecturer in hepatology and basic science at the University of Basel. She has published in numerous peer reviewed journals on Hepatitis C virus infection and liver immunology. She is a recipient of the Pfizer Research Prize in Switzerland, the Senior Hepatology Prize of the Swiss Society of Gastroenterology, and the EASL Sheila Sherlock Postdoctoral Fellowship award. She is an advocate for women in science and women in hepatology.

Faculty

 
Pietro Lampertico

Professor Pietro Lampertico is Full Professor in the Gastroenterology, Director of the Gastroenterology and Hepatology Division. He is also head of the “A. M. e A. Migliavacca” Center for Liver Disease at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy. In the Gastroenterology Unit, Professor Lampertico is primarily involved in the clinical management of chronic viral hepatitis outpatients, particularly those with CHB and CHD. His research interests include the treatment of patients with chronic hepatitis/cirrhosis due to HBV and HDV, the long-term outcome of cirrhotic patients undergoing antiviral treatment, and the diagnosis and management of antiviral resistance to oral nucleos(t)ide analogues.

Heiner Wedemeyer

Heiner Wedemeyer is Professor and Chairman of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School since April 1, 2020. His long-term research interest is in liver diseases with special focus on viral hepatitis, liver transplantation and hepatocellular carcinoma. He has been principal investigator in numerous clinical trials, focusing on antiviral therapy and immunotherapy of viral hepatitis B, C, D and E. Heiner Wedemeyer is member of several scientific organizations and was Secretary General of the European Association for the Study of the Liver from 2009 to 2011.

Log in to post comments
Liver Tumours
Liver Cancer Explained

Liver Cancer Explained

Infographics
View
General Hepatology
EASL Journal Club

EASL Journal Club

View
Immune-Mediated and Cholestatic Diseases
Online Course: Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection

Online Course: Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection

Online Courses
View
Metabolism, Alcohol & Toxicity
Online course: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Online course: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Online Courses
View
General Hepatology
Online course: EASL–EFSUMB Ultrasound of the liver

Online course: EASL–EFSUMB Ultrasound of the liver

Online Courses
View
Basic Science
 Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

Podcasts
View
Liver Tumours
Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz
View
General Hepatology
Online course: EASL–ESPEN Nutrition in liver disease

Online course: EASL–ESPEN Nutrition in liver disease

Online Courses
View
General Hepatology
EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

On-demand Webinars
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

Podcasts
View